Ares Management profits rise as fee-related earnings hit $464M
Ares Management (NYSE:ARES) reported its financial results for the first quarter ended March 31, 2026, demonstrating continued growth in its core management business.
United States Últimas notícias
Todas as matérias desta categoria, das mais recentes às mais antigas.
Technology
Genius Sports completes acquisition of Legend Media Network to deepen iGaming reach
Genius Sports (NYSE:GENI) has finalized its acquisition of Legend, a prominent digital sports and gaming media network.
Technology
Protolabs profit more than doubles as CNC machining drives record revenue
Proto Labs (NYSE:PRLB) reported record-breaking financial results for the first quarter of 2026, headlined by a more than 120% increase in GAAP net income.
Technology
Estée Lauder profits jump 40% as recovery plan offsets luxury slump
The Estée Lauder Companies (NYSE:EL) reported a 5% increase in net sales to $3.7 billion for the third quarter ended March 31, 2026, as the company’s strategic "Profit Recovery and Growth Plan" (PRGP) began to deliver tangible bottom-line results.
Oil and Gas
Linde profit hits $1.86B as project start-ups and pricing drive growth
Linde (NASDAQ:LIN) reported a strong start to 2026, with first-quarter net income rising 11% to $1.86 billion.
Industrials
LyondellBasell completes sale of key European assets to AEQUITA as strategic reset continues
LyondellBasell (NYSE:LYB) reached a pivotal milestone in its European strategic assessment today, May 1, 2026, with the successful completion of the sale of select European olefins and polyolefins assets to AEQUITA.
Energy
Portland General profits pressured by mild winter as data center demand surges
Portland General Electric Company (NYSE:POR) reported first-quarter 2026 financial results that reflected the dual impact of a historically mild winter and a rapidly expanding industrial base.
FDA advisory committee backs AstraZeneca’s Truqap for aggressive prostate cancer
The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recommended the approval of AstraZeneca’s (NYSE:AZN) Truqap (capivasertib) for patients with a particularly aggressive form of prostate cancer.
Auto and cars
Li Auto deliveries steady at 34,000 as flagship L9 Livis debuts with proprietary AI chip
Li Auto (NASDAQ:LI) reported vehicle deliveries of 34,085 for April 2026, a performance that remains largely flat year-over-year but reflects a stable trajectory as the company transitions its product lineup.
Auto and cars
NIO deliveries jump 23% as multi-brand strategy gains momentum
NIO (NYSE:NIO) reported a significant acceleration in vehicle deliveries for April 2026, handing over 29,356 vehicles to customers.
Health
Kodiak Sciences to present strong KSI-101 results at major vision conferences
Kodiak Sciences (NASDAQ:KOD) is set to present a series of clinical and preclinical advances at the American Uveitis Society (AUS) and the Association for Research in Vision and Ophthalmology (ARVO) annual meetings between May 2 and May 7, 2026.
Education
Pearson sales rise 4% as virtual learning demand offsets assessment slump
Pearson (NYSE:PSO) reported a 4% increase in underlying group sales for the first quarter of 2026, signaling a resilient performance as the company continues its pivot toward digital and enterprise-led growth.